Maria Bartkus, MD
Neurology · Foxboro, MANPI 1780246736
Payments from drug & device makers
Across 125 payments — averaging $24.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- EMD Serono, Inc.$432
- SK Life Science, Inc.$337
- TG Therapeutics, Inc.$308
- AbbVie$234
- AstraZeneca$199
- Lundbeck LLC$188
- plus $1K from 27 others
What the payments were for
- Food & beverage$3,108100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| EMD Serono, Inc. | 24 | $432 |
| SK Life Science, Inc. | 11 | $337 |
| TG Therapeutics, Inc. | 5 | $308 |
| AbbVie | 10 | $234 |
| AstraZeneca(2 entities) | 9 | $199 |
| Lundbeck LLC | 8 | $188 |
| Eisai Inc. | 6 | $175 |
| Biogen | 5 | $116 |
| MDD US Operations, LLC | 1 | $116 |
| UCB, Inc. | 4 | $107 |
| Genentech USA, Inc. | 5 | $99 |
| Argenx US, Inc. | 3 | $85 |
| Novartis | 3 | $70 |
| Kedrion Biopharma, Inc. | 3 | $63 |
| Ipsen Biopharmaceuticals, Inc | 2 | $55 |
| Amgen | 3 | $50 |
| CSL Behring | 2 | $50 |
| Vanda Pharmaceuticals Inc. | 2 | $46 |
| Alnylam Pharmaceuticals Inc. | 2 | $45 |
| Catalyst Pharmaceuticals, Inc. | 2 | $39 |
| Tanabe Pharma America, Inc. | 2 | $36 |
| Pfizer | 2 | $32 |
| Neuropace, Inc. | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Invivyd Inc | 1 | $24 |
| Mallinckrodt Hospital Products Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $23 |
| Grifols USA, LLC | 1 | $22 |
| Life Molecular Imaging Ltd | 1 | $21 |
| ANI Pharmaceuticals, Inc. | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Neurelis, Inc. | 1 | $14 |
| Cycle Pharmaceuticals Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,108 in reported general payments places this provider in the 60th percentile of 761 neurology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 32 | $396 |
| Duloxetine Hcl | 14 | $179 |
Paid to pharmacies, not to this prescriber.
Other neurology in Foxboro
- Salvatore NapoliFoxboro$3.3M
- Stephanie RutrickBoston$31.4M
- Scott PlotkinBoston$26.3M
- Patrick WenBoston$18.2M
- James BerryBoston$8.9M
- Isabel Arrillaga-RomanyBoston$8.2M
- Donald MarksPlymouth$7.8M
- Mahmut GurolBoston$7.4M
- Gad MarshallBoston$6M
- Shawn MurphyBoston$5.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.